Evidence map›Paper›PMID 41337487›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Structural insights into the role of eIF3 in translation mediated by the HCV IRES.

Wakana Iwasaki, Kazuhiro Kashiwagi, Ayako Sakamoto, Madoka Nishimoto, Mari Takahashi, Kodai Machida, Hiroaki Imataka, Akinobu Matsumoto, Yuichi Shichino, Shintaro Iwasaki and 2 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Wakana IwasakiLaboratory for Translation Structural Biology, RIKEN Center for Integrative Medical Sciences, Yokohama 230-0045, Japan.ORCID 0000-0002-0161-777X
Kazuhiro KashiwagiLaboratory for Translation Structural Biology, RIKEN Center for Integrative Medical Sciences, Yokohama 230-0045, Japan.ORCID 0000-0001-6470-5817
Ayako SakamotoLaboratory for Translation Structural Biology, RIKEN Center for Integrative Medical Sciences, Yokohama 230-0045, Japan.ORCID 0000-0002-9040-429X
Madoka NishimotoLaboratory for Translation Structural Biology, RIKEN Center for Integrative Medical Sciences, Yokohama 230-0045, Japan.
Mari TakahashiLaboratory for Translation Structural Biology, RIKEN Center for Integrative Medical Sciences, Yokohama 230-0045, Japan.
Kodai MachidaDepartment of Applied Chemistry, Graduate School of Engineering, University of Hyogo, Himeji, Hyogo 671-2201, Japan.ORCID 0000-0003-4973-9685
Hiroaki ImatakaDepartment of Applied Chemistry, Graduate School of Engineering, University of Hyogo, Himeji, Hyogo 671-2201, Japan.
Akinobu MatsumotoDivision of Biological Science, Graduate School of Science, Nagoya University, Nagoya 464-8602, Japan.ORCID 0000-0002-4077-3935
Yuichi ShichinoRNA Systems Biochemistry Laboratory, RIKEN Cluster for Pioneering Research, Wako, Saitama 351-0198, Japan.ORCID 0000-0002-0093-1185
Shintaro IwasakiRNA Systems Biochemistry Laboratory, RIKEN Cluster for Pioneering Research, Wako, Saitama 351-0198, Japan.ORCID 0000-0001-7724-3754
Koshi ImamiProteome Homeostasis Research Unit, RIKEN Center for Integrative Medical Sciences, Yokohama 230-0045, Japan.
Takuhiro ItoLaboratory for Translation Structural Biology, RIKEN Center for Integrative Medical Sciences, Yokohama 230-0045, Japan.ORCID 0000-0003-3704-5205

Funding

Japan Agency for Medical Research and Development (AMED) JP23gm6910005Japan Agency for Medical Research and Development (AMED) JP24gm1410001MEXT | Japan Society for the Promotion of Science (JSPS) JP19K06533MEXT | Japan Society for the Promotion of Science (JSPS) JP21H05281MEXT | Japan Society for the Promotion of Science (JSPS) JP22H02549MEXT | Japan Society for the Promotion of Science (JSPS) JP23K05673MEXT | JST | Fusion Oriented REsearch for disruptive Science and Technology (FOREST) JPMJFR214L
6 · The paper itself

Abstract

The genomes of various RNA viruses and a subset of human genes contain structured RNA elements termed internal ribosomal entry sites (IRESs) to initiate translation in a cap-independent manner. The well-studied IRES from Hepatitis C virus (HCV) binds to eukaryotic initiation factor 3 (eIF3), but how the HCV IRES harnesses eIF3 for viral translation remains unclear. Here, we determined multiple cryo-EM structures in which the HCV IRES binds simultaneously to the ribosome and eIF3, covering steps from initiation to elongation. The eIF3 core subunits are displaced from the ribosome by binding more tightly to subdomain IIIb of the HCV IRES. However, cross-linking mass spectrometry suggested that the eIF3 noncore subunits in the HCV-IRES-mediated elongation complex remain in similar positions on the ribosome to those observed in the cap-mediated initiation complex. This currently determined configuration of eIF3 core and noncore subunits reveals the mechanisms through which the HCV IRES overcomes the competition with the host mRNA and promotes viral mRNA translation by utilizing eIF3. Interestingly, cryo-EM structures also revealed that the N-terminal domain of the eIF3 c-subunit (eIF3c-NTD) binds to the large ribosomal subunit (60S) during elongation. These findings suggest that eIF3 contributes to HCV IRES-mediated translation not only during initiation but also elongation and potentially in reinitiation. The interaction between the eIF3c-NTD and the 60S ribosome is likely to occur in general translation processes as well, contributing to 60S joining or eIF3 stabilization on the elongating ribosome.

Indexed as

Eukaryotic Initiation Factor-3HepacivirusInternal Ribosome Entry SitesProtein BiosynthesisRNA, ViralCryoelectron MicroscopyHumansProtein BindingRibosomesEukaryotic Initiation Factor-3Internal Ribosome Entry SitesRNA, Viralcryo-EMeIF3IRESribosomevirus

Identifiers

PMID41337487
PMCPMC12704709

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.